James McFarland

18PUBLICATIONS
114CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer geneticsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 07, 2024
Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries.

Sean A Misek, Aaron Fultineer, Jeremie Kalfon

|May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.

Ricardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski

|Dec 28, 2022
A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in Carcinomas.

Lisa D Cervia, Tsukasa Shibue, Ashir A Borah

|Jul 13, 2022
Computational estimation of quality and clinical relevance of cancer cell lines.

Lucia Trastulla, Javad Noorbakhsh, Francisca Vazquez

|Jul 08, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.

Jessica W Tsai, Paloma Cejas, Dayle K Wang

|Apr 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer.

Daniel P Bondeson, Brenton R Paolella, Adhana Asfaw

Pageof 3